Search results for Metaphore Biotechnologies

Metaphore Biotechnologies, Developer of Functional Antibody AI Drug Discovery Platform, Receives Investment from TOHO Ho...

On the 6th, TOHO Ventures, operated by Global Brain, announced that it has executed an investment in Metaphore Biotechnologies, a company developing an AI platform to accelerate th...

Generare raises €20M to decode the 97% of microbial chemistry

The Paris techbio company screens microbial genomes to find molecules that evolution spent three billion years producing, and claims to have characterised more novel small molecule...

Rebranded Belgian biotech lands $125M for rescued Galapagos drug candidates

After launching in 2025 as a refuge for shipwrecked assets from Galapagos, Onco3R Therapeutics is rebranding as Coultreon Biopharma and filling its treasure chest with a $125 milli...

mbiomics raises €30M Series A to take its microbiome cancer co-therapy into clinical trials

The Munich techbio company is developing a live bacterial product designed to enhance immune checkpoint inhibitor response in advanced melanoma, with a Phase 1B study planned for 2...

Revolution Medicines

Revolution Medicines Anonymous (not verified) Tue, 05/05/2026 - 02:20 field_thread_url https://cafepharma.com/boards/threads/revolution-medicines.709803/...

Cell therapy biotech Obsidian leverages Galera reverse merger to go public

After initiating a wind-down more than 18 months ago and exploring liquidation, Galera Therapeutics has found a partner via a reverse merger with Obsidian Therapeutics that will ta...

BiomX Inc. (PHGE) Shareholder/Analyst Call Prepared Remarks Transcript

Anthropic buys biotech startup Coefficient Bio in $400M deal: Reports

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer.

SeaX Ventures leads US$2M seed round in precision fermentation startup Melazyme

Melazyme, a precision fermentation company developing high-performance functional biomolecules, has closed a US$2 million seed round led by SeaX Ventures, with participation from S...

Hong Kong-listed biotech firm uses AI to produce nano-rockets to deliver life-saving drugs

Shares of METiS TechBio surged 173 per cent on their Hong Kong debut on Wednesday as the AI-driven drug design start-up’s initial public offering drew strong demand from investors...

€1M raised to develop next-generation bioactives through precision fermentation

European farmers are being asked to produce more with fewer tools. Since 2009, roughly 50% of approved synthetic active substances have been withdrawn from the EU market. While bio...

HexemBio raises $10.4M for a stem cell rejuvenation therapy

The Berkeley biotech is backing a Nature-published approach that recreates the embryonic environment where blood stem cells first form, rather than reprogramming aged cells chemica...

Top biotech deals in March 2026 

Discover what were the top biotech deals that were signed in March 2026. From small molecules to antibodies, M&A activity was high. The post Top biotech deals in March 2026  ap...

With $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidate

In the sprawling metropolis of Houston, a new biotech has emerged to tackle the biology underlying a lung disease that has no clear cause. Oorja Bio launched yesterday afternoon wi...

Oorja, run by Acceleron veterans, launches to make new fibrosis drugs

The biotechnology startup emerged from stealth with a peptide drug it claims to have the potential to reverse lung scarring in people with idiopathic pulmonary fibrosis.

Merck KGaA, Remepy team up on software-enhanced hybrid drugs for rare tumors

German drugmaker Merck KGaA is teaming up with Israeli biotech Remepy to develop so-called hybrid drugs that pair a pharmaceutical with a personalized, AI-driven digital component...

altM: Scaling bio-based materials from agri-residue

altM converts agricultural residue into industrial biomaterials. Founded by ex-Tesla leaders, the startup is scaling sustainable chemistry from India.

DeepSeMS Unveils Ocean Microbiome’s Hidden Biosynthetic Potential

In a groundbreaking leap for biotechnology and drug discovery, a team of researchers has unveiled DeepSeMS, a novel large language model designed to decipher the complex chemical s...

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnolo...

Argobio: the venture model building Europe’s next biotech champions

Our guest today is Thierry Laugel, Managing Partner of Kurma & Chairman of Argobio. Argobio has co-founded several companies from top European academic labs. The post Argobio:...

Prime Venture, Leo Capital back biotech startup StrainX in $13M round

Prime Venture Partners and Leo Capital lead investment as the IIT Delhi-founded startup bets on precision fermentation and bio-manufacturing for global markets.

Proteins.1 Launches to Develop Single Molecule Protein Amplification Tech for Diagnostics

Proteins.1 launches to commercialize a technology enabling ultra-sensitive detection of proteins at the single-molecule level, with the aim of transforming early disease diagnostic...

This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million

Structure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary conditions.

This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million

Structure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary conditions.